AMLN (DIABETES DRUGS) Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : AMLN (DIABETES DRUGS)

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: Toby Zidle who wrote (1288)	4/2/1998 1:49:00 PM
From: Toby Zidle	Read Replies (2) of 2173

The financial situation sounds like, indeed, it could become critical here. Like looming bankruptcy. That's why I'd have to disagree with analyst Kim's quoted assessment. "The question that still remains is whether they have a product and whether it works," Kim said. "Changing management is not really changing the issue at hand." Actually, changing management is exactly the issue. The answer is in finding strategic direction: whether to issue debt or equity, where to find key partners, how to approach marketing in Europe, finding an optimum test strategy to satisfy the FDA. It's management, not product, that supplies the answer. As a shareholder, I'd like to say I'm optimistic for the company's future and dispense the appropriate soothing platitudes. But I'm not. I'm just planning to wait and see. [This message was intended as a reply to Henry Niman, message #1289.]

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next